Navigation Links
Studies Presented at AACR Annual Meeting Highlight Multiple Immunomodulatory Mechanisms of Peregrine's PS-Targeting Antibodies
Date:4/21/2009

cell lung cancer. A Phase I bavituximab monotherapy trial in advanced solid cancers is also continuing.

(1) Monica L. Friedrich, Claudia I. Guevara, Longen Zhou, Daniel Falcon, Cristina Bautista, Michael Brown, Anita Kavlie, Connie Chang, Bruce Freimark. Peregrine Pharmaceuticals, Inc., Tustin, CA, Affitech AS, Oslo, Norway. Induction of chemokines and cytokines by human phosphatidylserine antibody facilitates cell-mediated anti-tumor responses. In: Proceedings of the 100th Annual Meeting of the American Association for Cancer Research; 2009 Apr 18-22; Denver, CO. Philadelphia (PA): AACR; 2009. Abstract 2408

(2) Xianming Huang, Dan Ye, Philip Thorpe, Anita Kavlie. UT Southwestern Medical Ctr., Dallas, TX, Affitech AS, Oslo, Norway. A novel anti-phosphatidylserine antibody that promotes dendritic cell maturation. In: Proceedings of the 100th Annual Meeting of the American Association for Cancer Research; 2009 Apr 18-22; Denver, CO. Philadelphia (PA): AACR; 2009. Abstract 2407

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and serious viral infections. The company is pursuing three separate clinical programs in cancer and hepatitis C virus infection with its lead product candidates bavituximab and Cotara(R). Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (www.avidbio.com), which provides development and biomanufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at www.peregrineinc.com.

Safe Harbor Statement: Statements in this press release which are not purely historical, including s
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients
2. Alimera Sciences Iluvien(TM) Phase 3 Studies for DME Pass Final DSMB Review Prior to October Readout
3. Cynosure Announces Presentation of Favorable Results from Post-Marketing Studies of Smartlipo MPX
4. Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack
5. Avineuro Pharmaceuticals, Inc. Announces Beginning of Phase I Clinical Studies of AVN-211, Potent Small Molecule for Treatment of Schizophrenia.
6. Studies Show Combination Laser Therapy Effective At Clearing Acne, Reducing Oil Production
7. Prescient Medical Achieves Milestones in Clinical Studies of vProtect(TM) Luminal Shield
8. Intellect Neurosciences, Inc. Announces Independent Studies on Copper Binding Properties of its Lead Candidate OXIGON(TM)
9. BN ImmunoTherapeutics Updates on Phase I/II Studies With Breast Cancer Vaccine
10. Oridion Announces Significant Medical Studies Presented at STA
11. Takeda Initiates Two Phase III Studies with Vedolizumab (MLN0002) in Patients with Inflammatory Bowel Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2015)... BARCELONA, Spain , July 4, 2015 /PRNewswire/ ... to first-line chemotherapy for patients with unresectable metastatic ... Progression-Free Survival in that organ Patients ... spread only to the liver experienced the greatest ... from the addition of SIR-Spheres Y-90 resin microspheres ...
(Date:7/3/2015)... , July 3, 2015 ... Monitoring & Cardiac Rhythm Management Market ECG, Implantable ... Defibrillator, Implantable Cardioverter Defibrillator, Dual Chamber Pacemaker, CRT-D, ... MarketsandMarkets, the global Cardiac Monitoring (CM) and Cardiac ... reach $26,646.5 Million by 2020 from $21,137.7 Million ...
(Date:7/3/2015)... 3, 2015 Der ... bestimmter Abschlussbedingungen eine 100-prozentige Beteiligung am Unternehmen ... Mit dieser Übernahme dringt Lupin in den ... von 765 Mrd. RUB im Jahr 2014 ... gehörte (IMS Health). Seit über einem Jahrzehnt ...
Breaking Medicine Technology:New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 2New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 3New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 4Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4Lupin übernimmt Biocom aus Russland 2Lupin übernimmt Biocom aus Russland 3
... BRUNSWICK, N.J. and IRVINE, Calif., Oct. 18, 2011 ... today announced they had entered into a collaboration ... products. Under the terms of the agreement, Stason ... expertise to develop and manufacture products for Amerigen ...
... Oct. 18, 2011 ICAP Patent Brokerage ... largest intellectual property brokerage and patent auction firm, ... effectively protects stethoscope heads without impacting sound transmission ... http://photos.prnewswire.com/prnh/20100614/CG20517LOGO ) Background ...
Cached Medicine Technology:Amerigen Pharmaceuticals and Stason Pharmaceuticals Enter Into Collaboration Agreement for Development of Generic Oral Oncology Products 2Stethocap Disposable Stethoscope Covers - a Sound Solution: ICAP Patent Brokerage Offers to Sell IP Disclosing Effective Protection for Stethoscope Heads Without Impacting Sound Transmission 2
(Date:7/6/2015)... ... July 06, 2015 , ... The School of ... to support a three-year effort to reduce rates of diabetes and cardiovascular disease ... partnership with the Morehouse School of Medicine’s Prevention Research Center and the Satcher ...
(Date:7/6/2015)... ... July 06, 2015 , ... Diabetes affects many of ... than 29 million Americans have diabetes, the majority of which are Type 2. However, ... or more than one in three, have prediabetes (abnormally high blood sugar levels). Without ...
(Date:7/5/2015)... ... July 05, 2015 , ... Women's Excellence in Wellness, powered ... These classes are geared towards families that want their children to stay active ... , The fitness class will take place TUESDAYS at 4:30pm. Questions? Call 248-601-6683. ...
(Date:7/4/2015)... ... July 04, 2015 , ... Earlier ... results of an annual member survey , detailing the most common plastic ... the group broke that raw data down into charts detailing demographic trends and ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... ... for enrollment on July 2nd creating a buzz of media attention. In an ... published online by HonestyFirstReviews.com's Tiffany Hendricks. , "These days many people are feeling ...
Breaking Medicine News(10 mins):Health News:Georgia State, Morehouse Partner To Tackle Diabetes, Heart Disease In Atlanta’s Minority Communities 2Health News:115 Million in the U.S. could beat diabetes with the help of a new app 2Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 2Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 3Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3
... Some people are more likely than others to have alcohol-related ... brain, according to a new study. Researchers examined MRI ... alcohol-related blackouts and 12 people without a history of blackouts ... with and without alcohol. The findings are published online ...
... scientific sessions will be devoted to the latest advances ... Failure Congress 2012. The latest results from drugs and ... Devices are one of the hottest topics in heart ... main theme, "Treatment of heart failure: integrating pharmacology and ...
... TUESDAY, March 20 (HealthDay News) -- A state,s level ... study says. Researchers from Brigham and Women,s Hospital ... levels of financial inequality in each state, and then ... women nationwide who took part in the U.S. Women,s ...
... in serotonin signaling in the brain may contribute to ... behavior," Vanderbilt University researchers report. Serotonin is a ... gap between nerve cells. The supply of serotonin is ... team of Vanderbilt researchers led by Randy Blakely and ...
... Dresden-Rossendorf (HZDR) celebrated its 20th anniversary with a ... Technische Sammlungen Dresden (Dresden Technology Collections). During ... the last year were honored in the presence ... Dresden [Dresden University of Technology], and Museum Director ...
... School of Medicine in St. Louis have shown that a ... leukemia, a cancer of the white blood cells. Instead of ... of the bone marrow and into the bloodstream, where they ... at clearing these leukemia cells from the blood," says Geoffrey ...
Cached Medicine News:Health News:The world's largest heart failure congress -- Heart Failure Congress 2012 2Health News:The world's largest heart failure congress -- Heart Failure Congress 2012 3Health News:Less Heart Disease Among Women in Wealthier States: Study 2Health News:Novel mouse model for autism yields clues to a 50-year-old mystery 2Health News:Dresden's Helmholtz Center celebrates anniversary and presents HZDR awards 2Health News:Dresden's Helmholtz Center celebrates anniversary and presents HZDR awards 3Health News:Drug makes leukemia more vulnerable to chemo 2Health News:Drug makes leukemia more vulnerable to chemo 3
The cordless Simon Dermatome with rechargeable battery is used to harvest split-thickness skin grafts and for debridement....
Forceps with round handle, straight...
Castroviejo microscopic needle holder...
Microscopic scissors, curved...
Medicine Products: